Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

The investigators are trying a combination vaginal product of higher dose metronidazole combined with miconazole to see if it is effective in treating vaginal trichomonas.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Alabama at Birmingham
• Collaborator: Embil Pharmaceutical Co. Ltd
• Treatments: Metronidazole

Criteria

Inclusion Criteria:

• presence of trichomonas

Exclusion Criteria:

• pregnant or nursing

• known immunodeficiency

• allergy to study drugs

• concurrent yeast infection

• history of seizures or peripheral neuropathy

• unwillingness to abstain from alcohol during treatment period and for 48 hrs after concurrent lithium

• anticoagulation therapy, and abuse

• patient expected to have menses within 8 days of enrollment